REQUEST A DEMO
Total
USD $0.00
Search more companies

Diamond Biofund Inc. (Taiwan, China)

Main Activities: Funds, Trusts, and Other Financial Vehicles
Full name: Diamond Biofund Inc. Profile Updated: March 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Diamond Biofund Inc. is a large-scale sustainable biotech venture capital, focusing on the field of biotech medical investment, including new drug research and development, high-level medical equipment, innovative medical service technology, medical access, agricultural biotechnology, etc. The main products of the company include capital professional services: professional evaluation, system support, friendly exit. The company was established in 2013 and is headquartered in Taipei City, Taiwan.

Headquarters
10F., No. 236, Sec. 4, Xinyi Rd., Da'an Dist., Taipei City
Taipei City; Taipei City;

Contact Details: Purchase the Diamond Biofund Inc. report to view the information.

Website: http://www.diamondbiofund.com

Basic Information
Total Employees:
Purchase the Diamond Biofund Inc. report to view the information.
Outstanding Shares:
Purchase the Diamond Biofund Inc. report to view the information.
Financial Auditors:
Purchase the Diamond Biofund Inc. report to view the information.
Incorporation Date:
January 09, 2013
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
14.37%
Purchase this report to view the information.
14.37%
Purchase this report to view the information.
2.5%
Subsidiaries
Tetanti AgriBiotech Inc.
31.6%
20.00
20%
CHO Pharma, Inc.
16.78%
Company Performance
Financial values in the chart are available after Diamond Biofund Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
38.92%
Total operating revenue
38.98%
Operating profit (EBIT)
36.74%
EBITDA
37.42%
Net Profit (Loss) for the Period
36.84%
Total assets
-11.05%
Total equity
-12.12%
Operating Profit Margin (ROS)
3.72%
Net Profit Margin
3.55%
Return on Equity (ROE)
6.17%
Quick Ratio
-139.85%
Cash Ratio
-78.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?